Motley Fool Asset Management LLC Amgen Inc Transaction History

Motley Fool Asset Management LLC

$2.34 Billion
Q3 2025

A detailed history of Motley Fool Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Motley Fool Asset Management LLC holds 37,150 shares of AMGN stock, worth $12.7 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

37,150

Previous 27,913 33.09%

Holding current value

$12.7 Million

Previous $7.79 Million 34.52%

% of portfolio

0.45%

Previous 0.37%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$271.18 - $309.22 $2.5 Million - $2.86 Million	9,237 Added 33.09%	37,150 $10.5 Million
Q2 2025 Aug 01, 2025	BUY	$262.28 - $309.85 $766,906 - $906,001	2,924 Added 11.7%	27,913 $7.79 Million
Q1 2025 May 12, 2025	BUY	$258.59 - $327.36 $141,965 - $179,720	549 Added 2.25%	24,989 $7.79 Million
Q4 2024 Feb 12, 2025	BUY	$258.78 - $328.31 $727,948 - $923,536	2,813 Added 13.01%	24,440 $6.37 Million
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $242,553 - $264,505	784 Added 3.76%	21,627 $6.97 Million

Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $1.32 Million - $1.6 Million	5,009 Added 31.63%	20,843 $6.51 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $556,023 - $671,190	2,068 Added 15.02%	15,834 $4.5 Million
Q1 2024 May 08, 2024	SELL	$268.87 - $324.56 $556,560 - $671,839	-2,070 Reduced 13.07%	13,766 $3.91 Million
Q4 2023 Feb 02, 2024	BUY	$255.7 - $288.46 $143,703 - $162,114	562 Added 3.68%	15,836 $4.56 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $252,540 - $313,536	1,155 Added 8.18%	15,274 $4.11 Million
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $221,340 - $261,731	1,033 Added 7.89%	14,119 $3.13 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $69,769 - $85,036	-309 Reduced 2.31%	13,086 $3.16 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $83,824 - $106,509	-366 Reduced 2.66%	13,395 $3.52 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $22,894 - $25,821	-102 Reduced 0.74%	13,761 $3.1 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $233,939 - $260,334	-1,014 Reduced 6.82%	13,863 $3.42 Million
Q1 2022 May 04, 2022	BUY	$219.27 - $242.57 $63,588 - $70,345	290 Added 1.99%	14,877 $3.6 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $91,087 - $104,240	458 Added 3.24%	14,587 $3.28 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $4,245 - $4,974	-20 Reduced 0.14%	14,129 $3.01 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $406,662 - $451,162	1,741 Added 14.03%	14,149 $3.45 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $234,115 - $272,823	-1,055 Reduced 7.84%	12,408 $3.09 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $206,642 - $246,074	955 Added 7.64%	13,463 $3.1 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $366,523 - $407,603	1,562 Added 14.27%	12,508 $3.19 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $66,068 - $81,075	334 Added 3.15%	10,946 $2.58 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $51,573 - $68,401	283 Added 2.74%	10,612 $2.15 Million
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $116,931 - $150,297	618 Added 6.36%	10,329 $2.49 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $84,617 - $101,389	-486 Reduced 4.77%	9,711 $1.88 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $43,508 - $51,002	261 Added 2.63%	10,197 $1.88 Million
Q1 2019 May 07, 2019	BUY	$180.87 - $203.88 $302,595 - $341,091	1,673 Added 20.25%	9,936 $1.89 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $1.47 Million - $1.72 Million	8,263 New	8,263 $1.61 Million

Others Institutions Holding AMGN

# of Institutions

3,271

Shares Held

428M

Call Options Held

6.17M

Put Options Held

5.85M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $183B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Motley Fool Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Motley Fool Asset Management LLC with notifications on news.

Account

Motley Fool Asset Management LLC Amgen Inc Transaction History